These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. 7-Spiroindanyl derivatives of naltrexone and oxymorphone as selective ligands for delta opioid receptors. Ohkawa S; DiGiacomo B; Larson DL; Takemori AE; Portoghese PS J Med Chem; 1997 May; 40(11):1720-5. PubMed ID: 9171881 [TBL] [Abstract][Full Text] [Related]
14. Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand. Koolpe GA; Nelson WL; Gioannini TL; Angel L; Simon EJ J Med Chem; 1984 Dec; 27(12):1718-23. PubMed ID: 6209395 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of 7-arylmorphinans. Probing the "address" requirements for selectivity at opioid delta receptors. Gao P; Larson DL; Portoghese PS J Med Chem; 1998 Jul; 41(16):3091-8. PubMed ID: 9685249 [TBL] [Abstract][Full Text] [Related]
16. Opioid agonists and antagonists. 6-Desoxy-6-substituted lactone, epoxide, and glycidate ester derivatives of naltrexone and oxymorphone. Koolpe GA; Nelson WL; Gioannini TL; Angel L; Appelmans N; Simon EJ J Med Chem; 1985 Jul; 28(7):949-57. PubMed ID: 2409280 [TBL] [Abstract][Full Text] [Related]